It is currently Sun Oct 04, 2015 9:19 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

ABC News Primetime Medical Mystery Spot

Hello all and we send our best. In the past, I posted about a TV special we were interviewed for that was supposed to initially air in January. The spot is ABC News Primetime Medical Mystery titled - Chronic Lyme Disease as it pertains to ALS and MSi.

Delays, delays and delays and it is already fall. My last update from the producer, as of 9/6/07, is the executive producer is waiting for the proper ...
Read more : ABC News Primetime Medical Mystery Spot | Views : 1820 | Replies : 2 | Forum : Antibiotics

Increasing disease activity after treatment stops

Public release date: 12-Sep-2007

Contact: Angela Babb
American Academy of Neurology

Disease activity increases after MS patients stop drug
ST. PAUL, Minn. – People with multiple sclerosis who stop taking the drug natalizumab may experience a rebound increase in disease activity, according to a study published September 12, 2007, in the online edition of Neurology®, the medical journal ...

CoreControl Cooling Glove

Newish cooling glove that uses the hand's natural radiators to cool the bodys inner core. Case study on use with people with MS. ... tudies.pdf

My company in New Zealand is distributing these for athlete use so it was interesting to see this development. Unfortunately the gloves are very expensive $US 1,995. They are working on a consumer model for the future though.
Read more : CoreControl Cooling Glove | Views : 1208 | Replies : 2 | Forum : General Discussion

should we consider this?
Would this work as well as regular antibiotics?
Read more : should we consider this? | Views : 1806 | Replies : 2 | Forum : Antibiotics

Mitoxantrone observational study

The side effects can be nasty, but mitoxantrone can also be highly effective...

Mitoxantrone as induction treatment in aggressive relapsing remitting Multiple Sclerosis: treatment response factors in a 5-year follow-up observational study of 100 consecutive patients.

J Neurol Neurosurg Psychiatry. 2007 Sep 10
Emmanuelle LP E, Emmanuelle L E, Grégory T G, Marc C M, Jacques C J, Sean M S P, Gilles E G.
CHU Pontchaillou , RENNES, France.

BACKGROUND: Mitoxantrone was approved by ...
Read more : Mitoxantrone observational study | Views : 4411 | Replies : 4 | Forum : Novantrone

Aspartame not bad for your health

So, Aspartame isn't neurotoxic after all. Be aware that the Burdock Group has close ties with the food industry, and the study was funded by Ajinomoto company inc, which is a Japanese giant producing amino acids, livestock foodstuffs, and dietary substances. I'm not questioning their independence, just advising that you consume this with a pinch of monosodium glutamate:

Public release date: 11-Sep-2007

Contact: Ellen Ternes ...
Read more : Aspartame not bad for your health | Views : 1269 | Replies : 4 | Forum : General Discussion

shelley's ABX Adventure

eye doctor, eyr specialist, gp. heart specialist, gp, neor #1(dxd) gp
neor#2, gp, neor#3, gp, neor#4, gp, natural pathic doctor, gp, waiting to see neor#5

can not move my legs
can not feel my legs or feet
no use of left arm and -extremely panful
ms 'hug' - extremely painful
upper right are painful
right hand a little numb
head foggy
alot of headavhes
bladder issues
a couple of personal issues

Aug 16-Aug ...
Read more : shelley's ABX Adventure | Views : 2730 | Replies : 6 | Forum : Regimens

Tovaxin update

Opexa Therapeutics Reveals Steady Progress Of Phase IIb Trial Of Tovaxin And Recommendation Of Data Safety Monitoring Board - Quick Facts

Tuesday, September 11, 2007; Posted: 07:48 AM

(RTTNews) - Opexa Therapeutics, Inc. (OPXA | charts | news | PowerRating) on Tuesday revealed additional details on its 150-patient Phase IIb safety and efficacy study or TERMS study of Tovaxin in multiple sclerosis.

In the multicenter, randomized, double blind, placebo-controlled TERMS study all 150 patients have ...
Read more : Tovaxin update | Views : 1236 | Replies : 0 | Forum : Drug Pipeline

Stupid Study

I read this study and it really pissed me off. Is it really saying that the majority of us are just crazy?!!! What criteria do they use to determine that these people presented with psychiatric manifestations? These kind of studies just perpetuate the feelings of the outside world that our problems are only in our minds.

This version was published on July 1, 2007
Multiple Sclerosis, Vol. 13, No. 6, 749-753 (2007)
DOI: 10.1177/1352458506075032
© ...
Read more : Stupid Study | Views : 2943 | Replies : 19 | Forum : General Discussion

Tovaxin update from Opexa

You all (trial participants) are following this more closely than I am, so I don't know if this is old news...

Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis

Sep 11 2007, Business Wire - Opexa Therapeutics, a company involved in the development and commercialization of cell therapies, today provided an update on its 150-patient Phase IIb safety and efficacy study (TERMS) of Tovaxin in multiple sclerosis. The ...
Read more : Tovaxin update from Opexa | Views : 5943 | Replies : 23 | Forum : Tcelna (Tovaxin)


Login  •  Register


Total posts 227609 • Total topics 24031 • Total members 15392

Contact us | Terms of Service